{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T04:24:22Z","timestamp":1773980662144,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,10,29]],"date-time":"2011-10-29T00:00:00Z","timestamp":1319846400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s00280-011-1765-y","type":"journal-article","created":{"date-parts":[[2011,10,28]],"date-time":"2011-10-28T14:36:42Z","timestamp":1319812602000},"page":"781-787","source":"Crossref","is-referenced-by-count":12,"title":["Intrapleural paclitaxel for malignant pleural effusion from ovarian and breast cancer: a phase II study with pharmacokinetic analysis"],"prefix":"10.1007","volume":"69","author":[{"given":"Giuseppe","family":"Lombardi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Ornella","family":"Nicoletto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milena","family":"Gusella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasquale","family":"Fiduccia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizia","family":"Dalla Palma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Zuin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Donach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittorina","family":"Zagonel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,10,29]]},"reference":[{"key":"1765_CR1","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1378\/chest.116.3.760","volume":"116","author":"D Cheng","year":"1999","unstructured":"Cheng D, Rodriguez RM, Perkett EA, Rogers J, Bienvenu G, Lappalainen U, Light RW (1999) Vascular endothelial growth factor in pleural fluid. Chest 116:760\u2013765","journal-title":"Chest"},{"key":"1765_CR2","first-page":"296","volume":"11","author":"R Bennett","year":"2005","unstructured":"Bennett R, Maskell N (2005) Management of malignant pleural effusions. Curr Opin Pulm Med 11:296\u2013300","journal-title":"Curr Opin Pulm Med"},{"key":"1765_CR3","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/COC.0b013e3181aacbbf","volume":"33","author":"G Lombardi","year":"2010","unstructured":"Lombardi G, Zustovich F, Nicoletto MO, Donach M, Artioli G, Pastorelli D (2010) Diagnosis and treatment of malignant pleural effusion: a systematic literature review and new approaches. Am J Clin Oncol 33:420\u2013423","journal-title":"Am J Clin Oncol"},{"key":"1765_CR4","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(07)60708-9","volume":"369","author":"JP Janssen","year":"2007","unstructured":"Janssen JP, Collier G, Astoul P, Tassi GF, Noppen M, Rodriguez-Panadero F, Loddenkemper R, Herth FJ, Gasparini S, Marquette CH, Becke B, Froudarakis ME, Driesen P, Bolliger CT, Tschopp JM (2007) Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study. Lancet 369:1535\u20131539","journal-title":"Lancet"},{"key":"1765_CR5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0025-6196(11)60848-3","volume":"83","author":"JE Heffner","year":"2008","unstructured":"Heffner JE, Klein JS (2008) Recent advances in the diagnosis and management of malignant pleural effusions. Mayo Clin Proc 83:235\u2013250","journal-title":"Mayo Clin Proc"},{"key":"1765_CR6","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0954-6111(98)90294-3","volume":"92","author":"RP Perng","year":"1998","unstructured":"Perng RP, Chen YM, Wu MF, Chou KC, Lin WC, Liu JM, Whang-Peng J (1998) Phase II trial of intrapleural paclitaxel injection for non-small-cell lung cancer patients with malignant pleural effusions. Respir Med 92:473\u2013479","journal-title":"Respir Med"},{"key":"1765_CR7","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/00001813-199707000-00003","volume":"8","author":"RP Perng","year":"1997","unstructured":"Perng RP, Wu MF, Lin SY, Chen YM, Lin JY, Whang-Peng J (1997) A phase I feasibility and pharmacokinetic study of intrapleural paclitaxel in patients with malignant pleural effusions. Anticancer Drugs 8:565\u2013573","journal-title":"Anticancer Drugs"},{"key":"1765_CR8","first-page":"911","volume":"33","author":"FJ Molengraft van de","year":"1989","unstructured":"van de Molengraft FJ, Vooijs GP (1989) Survival of patients with malignancy-associated effusions. Acta Cytol 33:911\u2013916","journal-title":"Acta Cytol"},{"key":"1765_CR9","doi-asserted-by":"crossref","first-page":"385S","DOI":"10.1378\/chest.103.4_Supplement.385S","volume":"103","author":"TJ Lynch Jr","year":"1993","unstructured":"Lynch TJ Jr (1993) Management of malignant pleural effusions. Chest 103:385S\u2013389S","journal-title":"Chest"},{"key":"1765_CR10","doi-asserted-by":"crossref","unstructured":"Shaw P, Agarwal R (2004) Pleurodesis for malignant pleural effusions. Cochrane Database Syst Rev (1):CD002916","DOI":"10.1002\/14651858.CD002916.pub2"},{"key":"1765_CR11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000007183","volume":"45","author":"Y Tohda","year":"1999","unstructured":"Tohda Y, Iwanaga T, Takada M, Yana T, Kawahara M, Negoro S, Okishio K, Kudoh S, Fukuoka M, Furuse K (1999) Intrapleural administration of cisplatin and etoposide to treat malignant pleural effusions in patients with non-small cell lung cancer. Chemotherapy 45:197\u2013204","journal-title":"Chemotherapy"},{"key":"1765_CR12","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1378\/chest.121.3.821","volume":"121","author":"T Shoji","year":"2002","unstructured":"Shoji T, Tanaka F, Yanagihara K, Inui K, Wada H (2002) Phase II study of repeated intrapleural chemotherapy using implantable access system for management of malignant pleural effusion. Chest 121:821\u2013824","journal-title":"Chest"},{"key":"1765_CR13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1023\/A:1008203100410","volume":"8","author":"R Lerza","year":"1997","unstructured":"Lerza R, Vannozzi MO, Tolino G, Viale M, Bottino GB, Bogliolo G, Cerruti A, Castello G, Mencoboni M, Reggiardo G, Pannacciulli I, Esposito M (1997) Carboplatin and cisplatin pharmacokinetics after intrapleural combination treatment in patients with malignant pleural effusion. Ann Oncol 8:385\u2013391","journal-title":"Ann Oncol"},{"key":"1765_CR14","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1067\/mtc.2002.120712","volume":"123","author":"Y Ichinose","year":"2002","unstructured":"Ichinose Y, Tsuchiya R, Koike T, Yasumitsu T, Nakamura K, Tada H, Yoshimura H, Mitsudomi T, Nakagawa K, Yokoi K, Kato H (2002) A prematurely terminated phase III trial of intraoperative intrapleural hypotonic cisplatin treatment in patients with resected non-small cell lung cancer with positive pleural lavage cytology: the incidence of carcinomatous pleuritis after surgical intervention. J Thorac Cardiovasc Surg 123:695\u2013699","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1765_CR15","first-page":"54","volume":"12","author":"FH Hausheer","year":"1985","unstructured":"Hausheer FH, Yarbro JW (1985) Diagnosis and treatment of malignant pleural effusion. Semin Oncol 12:54\u201375","journal-title":"Semin Oncol"},{"key":"1765_CR16","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.ejca.2010.02.002","volume":"46","author":"X Wang","year":"2010","unstructured":"Wang X, Zhou J, Wang Y, Zhu Z, Lu Y, Wei Y, Chen L (2010) A phase I clinical and pharmacokinetic study of paclitaxel liposome infused in non-small cell lung cancer patients with malignant pleural effusions. Eur J Cancer 46:1474\u20131480","journal-title":"Eur J Cancer"},{"key":"1765_CR17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/JTO.0b013e3181c07ddc","volume":"5","author":"DR Jones","year":"2010","unstructured":"Jones DR, Taylor MD, Petroni GR, Shu J, Burks SG, Daniel TM, Gillenwater HH (2010) Phase I trial of intrapleural docetaxel administered through an implantable catheter in subjects with a malignant pleural effusion. J Thorac Oncol 5:75\u201381","journal-title":"J Thorac Oncol"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-011-1765-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-011-1765-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-011-1765-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T19:29:39Z","timestamp":1560886179000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-011-1765-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,29]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["1765"],"URL":"https:\/\/doi.org\/10.1007\/s00280-011-1765-y","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,29]]}}}